OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association of Adherence to a Healthy Diet with Cognitive Decline in European and American Older Adults: A Meta-Analysis within the CHANCES Consortium
Agnes A. M. Berendsen, Jae H. Kang, Ondine van de Rest, et al.
Dementia and Geriatric Cognitive Disorders (2017) Vol. 43, Iss. 3-4, pp. 215-227
Open Access | Times Cited: 556
Agnes A. M. Berendsen, Jae H. Kang, Ondine van de Rest, et al.
Dementia and Geriatric Cognitive Disorders (2017) Vol. 43, Iss. 3-4, pp. 215-227
Open Access | Times Cited: 556
Showing 1-25 of 556 citing articles:
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack, David A. Bennett, Kaj Blennow, et al.
Alzheimer s & Dementia (2018) Vol. 14, Iss. 4, pp. 535-562
Open Access | Times Cited: 7752
Clifford R. Jack, David A. Bennett, Kaj Blennow, et al.
Alzheimer s & Dementia (2018) Vol. 14, Iss. 4, pp. 535-562
Open Access | Times Cited: 7752
Alzheimer's disease
Philip Scheltens, Bart De Strooper, Miia Kivipelto, et al.
The Lancet (2021) Vol. 397, Iss. 10284, pp. 1577-1590
Open Access | Times Cited: 3009
Philip Scheltens, Bart De Strooper, Miia Kivipelto, et al.
The Lancet (2021) Vol. 397, Iss. 10284, pp. 1577-1590
Open Access | Times Cited: 3009
The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
Jeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Nature (2016) Vol. 537, Iss. 7618, pp. 50-56
Closed Access | Times Cited: 2556
Jeff Sevigny, Ping Chiao, Thierry Bussière, et al.
Nature (2016) Vol. 537, Iss. 7618, pp. 50-56
Closed Access | Times Cited: 2556
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
Bruno Dubois, Harald Hampel, Howard Feldman, et al.
Alzheimer s & Dementia (2016) Vol. 12, Iss. 3, pp. 292-323
Open Access | Times Cited: 1637
Bruno Dubois, Harald Hampel, Howard Feldman, et al.
Alzheimer s & Dementia (2016) Vol. 12, Iss. 3, pp. 292-323
Open Access | Times Cited: 1637
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
Clifford R. Jack, David A. Bennett, Kaj Blennow, et al.
Neurology (2016) Vol. 87, Iss. 5, pp. 539-547
Open Access | Times Cited: 1496
Clifford R. Jack, David A. Bennett, Kaj Blennow, et al.
Neurology (2016) Vol. 87, Iss. 5, pp. 539-547
Open Access | Times Cited: 1496
The Diagnosis and Management of Mild Cognitive Impairment
Kenneth M. Langa, Deborah A. Levine
JAMA (2014) Vol. 312, Iss. 23, pp. 2551-2551
Open Access | Times Cited: 1077
Kenneth M. Langa, Deborah A. Levine
JAMA (2014) Vol. 312, Iss. 23, pp. 2551-2551
Open Access | Times Cited: 1077
Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
Geert Jan Biessels, Florin Despa
Nature Reviews Endocrinology (2018) Vol. 14, Iss. 10, pp. 591-604
Open Access | Times Cited: 1002
Geert Jan Biessels, Florin Despa
Nature Reviews Endocrinology (2018) Vol. 14, Iss. 10, pp. 591-604
Open Access | Times Cited: 1002
Cognitive frailty: Rational and definition from an (I.A.N.A./I.A.G.G.) International Consensus Group
Eirini Kelaiditi, Matteo Cesari, Marco Canevelli, et al.
The journal of nutrition health & aging (2013) Vol. 17, Iss. 9, pp. 726-734
Open Access | Times Cited: 838
Eirini Kelaiditi, Matteo Cesari, Marco Canevelli, et al.
The journal of nutrition health & aging (2013) Vol. 17, Iss. 9, pp. 726-734
Open Access | Times Cited: 838
The Alzheimer's disease mitochondrial cascade hypothesis: Progress and perspectives
Russell H. Swerdlow, Jeffrey M. Burns, Shaharyar M. Khan
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2013) Vol. 1842, Iss. 8, pp. 1219-1231
Open Access | Times Cited: 693
Russell H. Swerdlow, Jeffrey M. Burns, Shaharyar M. Khan
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2013) Vol. 1842, Iss. 8, pp. 1219-1231
Open Access | Times Cited: 693
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Bruno Dubois, Nicolas Villain, Giovanni B. Frisoni, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 484-496
Open Access | Times Cited: 689
Bruno Dubois, Nicolas Villain, Giovanni B. Frisoni, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 484-496
Open Access | Times Cited: 689
The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
Reisa A. Sperling, Elizabeth C. Mormino, Keith A. Johnson
Neuron (2014) Vol. 84, Iss. 3, pp. 608-622
Open Access | Times Cited: 647
Reisa A. Sperling, Elizabeth C. Mormino, Keith A. Johnson
Neuron (2014) Vol. 84, Iss. 3, pp. 608-622
Open Access | Times Cited: 647
Mild Cognitive Impairment
Ronald C. Petersen
CONTINUUM Lifelong Learning in Neurology (2016) Vol. 22, Iss. 2, Dementia, pp. 404-418
Open Access | Times Cited: 645
Ronald C. Petersen
CONTINUUM Lifelong Learning in Neurology (2016) Vol. 22, Iss. 2, Dementia, pp. 404-418
Open Access | Times Cited: 645
Alzheimer's disease drug development pipeline: 2019
Jeffrey L. Cummings, Garam Lee, Aaron Ritter, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2019) Vol. 5, Iss. 1, pp. 272-293
Open Access | Times Cited: 629
Jeffrey L. Cummings, Garam Lee, Aaron Ritter, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2019) Vol. 5, Iss. 1, pp. 272-293
Open Access | Times Cited: 629
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)
Ingrid Arévalo-Rodríguez, Nadja Smailagic, Marta Roqué i Figuls, et al.
Cochrane library (2015)
Open Access | Times Cited: 625
Ingrid Arévalo-Rodríguez, Nadja Smailagic, Marta Roqué i Figuls, et al.
Cochrane library (2015)
Open Access | Times Cited: 625
Current and future treatments for Alzheimer’s disease
Konstantina G. Yiannopoulou, Sokratis G. Papageorgiou
Therapeutic Advances in Neurological Disorders (2012) Vol. 6, Iss. 1, pp. 19-33
Open Access | Times Cited: 597
Konstantina G. Yiannopoulou, Sokratis G. Papageorgiou
Therapeutic Advances in Neurological Disorders (2012) Vol. 6, Iss. 1, pp. 19-33
Open Access | Times Cited: 597
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
Chad J. Swanson, Yong Zhang, Shobha Dhadda, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 594
Chad J. Swanson, Yong Zhang, Shobha Dhadda, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 594
Clinical trials and late‐stage drug development for A lzheimer's disease: an appraisal from 1984 to 2014
L. S. Schneider, Francesca Mangialasche, Nancy C. Andreasen, et al.
Journal of Internal Medicine (2014) Vol. 275, Iss. 3, pp. 251-283
Open Access | Times Cited: 591
L. S. Schneider, Francesca Mangialasche, Nancy C. Andreasen, et al.
Journal of Internal Medicine (2014) Vol. 275, Iss. 3, pp. 251-283
Open Access | Times Cited: 591
Impact of multiple pathologies on the threshold for clinically overt dementia
Alifiya Kapasi, Charles DeCarli, Julie A. Schneider
Acta Neuropathologica (2017) Vol. 134, Iss. 2, pp. 171-186
Open Access | Times Cited: 564
Alifiya Kapasi, Charles DeCarli, Julie A. Schneider
Acta Neuropathologica (2017) Vol. 134, Iss. 2, pp. 171-186
Open Access | Times Cited: 564
Consensus classification of posterior cortical atrophy
Sebastian J. Crutch, Jonathan M. Schott, Gil D. Rabinovici, et al.
Alzheimer s & Dementia (2017) Vol. 13, Iss. 8, pp. 870-884
Open Access | Times Cited: 534
Sebastian J. Crutch, Jonathan M. Schott, Gil D. Rabinovici, et al.
Alzheimer s & Dementia (2017) Vol. 13, Iss. 8, pp. 870-884
Open Access | Times Cited: 534
Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease
Yaxing Gui, Hai Liu, LiShan Zhang, et al.
Oncotarget (2015) Vol. 6, Iss. 35, pp. 37043-37053
Open Access | Times Cited: 506
Yaxing Gui, Hai Liu, LiShan Zhang, et al.
Oncotarget (2015) Vol. 6, Iss. 35, pp. 37043-37053
Open Access | Times Cited: 506
Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease
Michael Egan, James Kost, Tiffini Voss, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 15, pp. 1408-1420
Open Access | Times Cited: 479
Michael Egan, James Kost, Tiffini Voss, et al.
New England Journal of Medicine (2019) Vol. 380, Iss. 15, pp. 1408-1420
Open Access | Times Cited: 479
Timely Diagnosis for Alzheimer’s Disease: A Literature Review on Benefits and Challenges
Bruno Dubois, Alessandro Padovani, Philip Scheltens, et al.
Journal of Alzheimer s Disease (2015) Vol. 49, Iss. 3, pp. 617-631
Open Access | Times Cited: 460
Bruno Dubois, Alessandro Padovani, Philip Scheltens, et al.
Journal of Alzheimer s Disease (2015) Vol. 49, Iss. 3, pp. 617-631
Open Access | Times Cited: 460
The Rotterdam Study: 2018 update on objectives, design and main results
M. Arfan Ikram, Guy Brusselle, Sarwa Darwish Murad, et al.
European Journal of Epidemiology (2017) Vol. 32, Iss. 9, pp. 807-850
Open Access | Times Cited: 416
M. Arfan Ikram, Guy Brusselle, Sarwa Darwish Murad, et al.
European Journal of Epidemiology (2017) Vol. 32, Iss. 9, pp. 807-850
Open Access | Times Cited: 416
Mediterranean Diet, Cognitive Function, and Dementia: A Systematic Review of the Evidence
Sara Petersson, Elena Philippou
Advances in Nutrition (2016) Vol. 7, Iss. 5, pp. 889-904
Open Access | Times Cited: 391
Sara Petersson, Elena Philippou
Advances in Nutrition (2016) Vol. 7, Iss. 5, pp. 889-904
Open Access | Times Cited: 391
